Apatinib for Metastatic Esophageal Cancer.

NCT02544737 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

29

Enrollment

OTHER

Sponsor class

Conditions

Esophageal Cancer
Metastatic Esophageal Cancer
Apatinib

Interventions

DRUG: Apatinib

Sponsor

Hangzhou Cancer Hospital